DILOTAB II, SINUS AND COLD RELIEF NON DROWSY (acetaminophen 325 mg, Phenylephrine HCl 5 mg) 2 tab...
FDA Drug Recall #D-0490-2022 — Class II — January 24, 2022
Recall Summary
| Recall Number | D-0490-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 24, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ultra Seal Corporation |
| Location | New Paltz, NY |
| Product Type | Drugs |
| Quantity | 2,685,700 packets |
Product Description
DILOTAB II, SINUS AND COLD RELIEF NON DROWSY (acetaminophen 325 mg, Phenylephrine HCl 5 mg) 2 tablet packets, Dist. by ZEE Medical Distributors, LLC Mason, OH 45040, NDC 42961-052-03
Reason for Recall
cGMP deviations
Distribution Pattern
Nationwide within the United States
Lot / Code Information
Lot #: AK9548, (L) 106, Exp. Date 04/2022; AK9647, (L)103, Exp. Date 06/2022; AK9598, Exp. Date 05/2022
Other Recalls from Ultra Seal Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0497-2022 | Class II | Pain & Sinus Reliever Pain Reliever/Nasal Decon... | Jan 24, 2022 |
| D-0482-2022 | Class II | Backache & Muscle Relief (acetaminophen 250 mg,... | Jan 24, 2022 |
| D-0506-2022 | Class II | MidNite Natural sleep aid Chewable Tablets Cher... | Jan 24, 2022 |
| D-0481-2022 | Class II | Multi-Symptom Cramp Relief (acetaminophen 325mg... | Jan 24, 2022 |
| D-0487-2022 | Class II | COLD TERMINATOR decongestant/cold relief (aceta... | Jan 24, 2022 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.